| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.009 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.01 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |